Avoiding overuse of adjuvant therapies
- PMID: 29921846
- DOI: 10.1038/s41571-018-0054-7
Avoiding overuse of adjuvant therapies
Comment on
-
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860917 Free PMC article. Clinical Trial.
-
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863451 Free PMC article. Clinical Trial.
Similar articles
-
Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapy.Curr Probl Cancer. 2003 Jan-Feb;27(1):13-6. doi: 10.1067/mcn.2003.120001a. Curr Probl Cancer. 2003. PMID: 12569344 Review. No abstract available.
-
Adjuvant chemotherapy in early breast cancer.Minerva Ginecol. 2012 Feb;64(1):53-65. Minerva Ginecol. 2012. PMID: 22334231 Review.
-
Progress in adjuvant chemotherapy for breast cancer: an overview.BMC Med. 2015 Aug 17;13:195. doi: 10.1186/s12916-015-0439-8. BMC Med. 2015. PMID: 26278220 Free PMC article. Review.
-
Adjuvant chemotherapy in early-stage breast cancer: what, when, and for whom?Surg Oncol Clin N Am. 2010 Jul;19(3):649-68. doi: 10.1016/j.soc.2010.03.007. Surg Oncol Clin N Am. 2010. PMID: 20620933 Review.
-
Cost effectiveness and other assessments of adjuvant therapies for early breast cancer.Oncology (Williston Park). 1995 Nov;9(11 Suppl):129-34. Oncology (Williston Park). 1995. PMID: 8608043 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical